2-micron family plasmid and use thereof

Details for Australian Patent Application No. 2004303597 (hide)

Owner Novozymes Biopharma UK Limited

Inventors Sleep, Darrell; Finnis, Christopher John Arthur

Agent Freehills

Pub. Number AU-B-2004303597

PCT Pub. Number WO2005/061719

Priority 0329722.3 23.12.03 GB

Filing date 23 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 27 November 2008

International Classifications

C12N 15/81 (2006.01) Mutation or genetic engineering - for yeasts

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061719 Priority application(s): WO2005/061719

21 June 2007 Change of Name(s) of Applicant(s), Section 104

  Delta Biotechnology Limited The name of the applicant has been changed to Novozymes Delta Limited

25 September 2008 Alteration of Name

  The name of the applicant has been altered to Novozymes Biopharma UK Limited 2005

25 September 2008 Application Accepted

  Published as AU-B-2004303597

27 November 2008 Application Accepted

  Published as AU-B-2004303597

14 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Dec 2008 2005

14 May 2009 Standard Patent Sealed

2 September 2010 Assignment Registered

  Novozymes Biopharma UK Limited The patent has been assigned to Novozymes Biopharma DK A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303599-Compositions of semi-interpenetrating polymer network

2004303594-Isopeptide gap junction modulators